Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748734 · ClinicalTrials.gov registry record · Phase 2
Cognitive Therapy in Reducing Depression in Patients With Cancer
A Phase 2 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT01748734 is a Phase 2 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 25 participants.
The verdict
NCT01748734, a Phase 2 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about treatment of depression in people who have any type of cancer. Cognitive therapy (CT) helps improve depressive symptoms by targeting patient's thoughts and behaviors. People who are depressed tend to have more negative or pessimistic thoughts. CT helps people evaluate the accuracy of their thoughts. By encouraging patients to develop more balanced views, symptoms of depression begin to improve
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER counseling intervention
- BEHAVIORAL behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01748734
The ClinicalTrials.gov registry entry for NCT01748734 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01748734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01748734 about?
NCT01748734 is a clinical study titled "Cognitive Therapy in Reducing Depression in Patients With Cancer". The purpose of this study is to learn about treatment of depression in people who have any type of cancer. Cognitive therapy (CT) helps improve depressive symptoms by targeting patient's thoughts and behaviors. People who are depressed tend to have more negative or pessimistic thoughts. CT helps peo...
What is the current status of trial NCT01748734?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2011-03.
What interventions are being tested in trial NCT01748734?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), counseling intervention (OTHER), behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01748734?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.